| 臺大學術典藏 |
2021-10-08T00:36:55Z |
Effects of root-end filling materials and eugenol on mitochondrial dehydrogenase activity and cytotoxicity to human periodontal ligament fibroblasts
|
Lin C.-P.; YI-JANE CHEN; Lee Y.-L.; Wang J.-S.; Chang M.-C.; Lan W.-H.; Chang H.-H.; Chao W.M.-W.; Tai T.-F.; Lee M.-Y.; Lin B.-R.; Jeng J.-H. |
| 臺大學術典藏 |
2021-09-27T05:32:42Z |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai Y.-T.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Lin C.-Y.; Chen Y.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:41Z |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
|
Liu P.-Y.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Lee Y.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:39Z |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
|
Tsai H.-Y.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
|
Lee Y.-L.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020
|
Chien Y.-C.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Ko W.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-14T02:45:52Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; JHONG-LIN WU; Tseng W.-P.; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-09-14T02:45:49Z |
Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan
|
Lin Y.-C.; Lee Y.-L.; Cheng C.-Y.; Tseng W.-P.; JHONG-LIN WU; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Chen S.-C.; Chen S.-Y.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-27T06:48:55Z |
Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review
|
KUAN-YIN LIN; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; Cheng A.; Sun H.-Y.; Chang S.-Y.; Liu C.-E.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:48Z |
Public health intervention strategies to contain hepatitis a outbreaks
|
KUAN-YIN LIN; Lee Y.-L.; Huang S.-H.; Chen G.-J.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:14Z |
Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review
|
KUAN-YIN LIN; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; Cheng A.; Sun H.-Y.; Chang S.-Y.; Liu C.-E.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:08Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:05Z |
Public health intervention strategies to contain hepatitis a outbreaks
|
KUAN-YIN LIN; Lee Y.-L.; Huang S.-H.; Chen G.-J.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study
|
Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; Hung C.-C.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YU-SHAN HUANG; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
High rates of misidentification of uncommon Candida species causing bloodstream infections using conventional phenotypic methods
|
YU-SHAN HUANG; Wang F.-D.; Chen Y.-C.; Huang Y.-T.; Hsieh M.-H.; Hii I.-M.; Lee Y.-L.; Ho M.-W.; Liu C.-E.; Chen Y.-H.; Liu W.-L. |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:19Z |
Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review
|
Lin K.-Y.; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; ARISTINE CHENG; Sun H.-Y.; Chang S.-Y.; Liu C.-E.; Hung C.-C. |
